MIT Researchers Discover New Potential Drug Targets for Alzheimer’s Disease

‘Hope’: Huge leap in dementia treatment

The Therapeutic Goods Administration has approved a new drug tipped to revolutionise the treatment of hundreds of thousands of Australians suffering through early-stage Alzheimer’s disease.

First Alzheimer’s blood test available in US in June

The test potentially makes it easier to find and treat patients with the memory-robbing disease. Read more at straitstimes.com.

Peachey Stone Freemasons Lodge raises over £1,000 for Alzheimer’s Society

Members of Peachey Stone Lodge No. 5993, part of Middlesex Freemasonry, have successfully raised more than £1,000 for the Alzheimer’s Society by completing the Trek 26 London Challenge on Saturday 17th May 2025.

MIT researchers discover new potential drug targets for Alzheimer’s disease

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.

FDA OKs blood test to help diagnose Alzheimer's

WASHINGTON — U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer's and identify patients who may benefit from drugs that can modestly slow the memory-destroying disease.

MIT, Harvard scientists make important breakthrough in Alzheimer’s research

Scientists at the Massachusetts Institute of Technology and Harvard Medical School have identified new targets for treating and preventing Alzheimer’s disease, according to MIT.Alzheimer’s disease is a neurodegenerative brain disease that affects people’s memory and other mental functions. Neurodegenerative diseases are characterized by cells ceasing to function or dying, and the diseases usually worsen over time.